This information was published on 2025-02-06T04:29:49 for IP Right Filed Published.
| Field | Value |
| (210) | 2519730 (IR 1832004) |
| (220) |
06 Jan 2025
|
| (511) (510) |
Class 5
Pharmaceutical preparations and substances for the treatment of neurological, neuropsychiatric, neurodegenerative, viral, metabolic, obesity, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, ophthalmic, respiratory, gastrointestinal, hormonal, dermatological, and immune system related diseases and disorders. |
| (540) | REJUTRIA |
| (550) | Word |
| (730) |
Biohaven Therapeutics Ltd.
|
Find out more about publications on the About page.